CASI - CASI Pharmaceuticals, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual
Subscribe to Premium to download historical data

Income Statement

All numbers in thousands
Breakdown
ttm
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Total Revenue
4,131
4,131
0
0
0
Cost of Revenue
3,935
3,935
-
-
0
Gross Profit
196
196
-
-
0
Operating Expenses
Research Development
9,748
9,748
8,507
7,595
4,646
Selling General and Administrative
30,439
30,439
17,997
3,156
4,775
Total Operating Expenses
40,187
40,187
26,504
10,751
9,421
Operating Income or Loss
-39,991
-39,991
-26,504
-10,751
-9,421
Interest Expense
-
-
8.208
14.976
33.808
Total Other Income/Expenses Net
-6,433
-6,433
-1,007
-19.891
-6.788
Income Before Tax
-45,362
-45,362
-27,472
-10,770
-9,453
Income from Continuing Operations
-45,362
-45,362
-27,472
-10,770
-9,453
Net Income
-46,032
-46,032
-27,472
-10,770
-9,453
Net Income available to common shareholders
-46,032
-46,032
-27,472
-10,770
-9,453
Basic EPS
-
-
-0.32
-0.18
-0.17
Diluted EPS
-
-
-0.32
-0.18
-0.17
Basic Average Shares
-
-
84,752
61,514
55,869
Diluted Average Shares
-
-
84,752
61,514
55,869
EBITDA
-
-37,838
-25,792
-10,637
-9,353